Drug
Norethindrone Acetate And Ethinyl Estradiol, Ethinyl Estradiol And Ferrous Fumarate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Amenorrhoea | 220 | 88.1 | 94.6 | signal |
| 2 | Metrorrhagia | 156 | 60.1 | 63.1 | signal |
| 3 | Menstruation Irregular | 108 | 27.0 | 27.9 | signal |
| 4 | Menorrhagia | 80 | 26.6 | 27.3 | signal |
| 5 | Dysmenorrhoea | 46 | 23.3 | 23.6 | signal |
| 6 | Menstruation Delayed | 29 | 18.5 | 18.6 | signal |
| 7 | Coeliac Disease | 23 | 15.5 | 15.6 | signal |
| 8 | Pregnancy | 27 | 8.8 | 8.9 | signal |
| 9 | Ovarian Cyst | 13 | 8.5 | 8.6 | signal |
| 10 | Vaginal Haemorrhage | 55 | 8.5 | 8.7 | signal |
| 11 | Product Dose Omission | 77 | 7.7 | 7.8 | signal |
| 12 | Libido Decreased | 14 | 7.5 | 7.5 | signal |
| 13 | Pelvic Pain | 20 | 7.3 | 7.3 | signal |
| 14 | Genital Haemorrhage | 14 | 7.1 | 7.2 | signal |
| 15 | Mood Swings | 32 | 6.6 | 6.7 | signal |
| 16 | Vaginal Discharge | 10 | 6.6 | 6.6 | signal |
| 17 | Breast Pain | 10 | 6.2 | 6.2 | signal |
| 18 | Embedded Device | 9 | 6.0 | 6.1 | signal |
| 19 | Therapeutic Response Unexpected | 40 | 5.9 | 5.9 | signal |
| 20 | Mood Altered | 22 | 5.3 | 5.4 | signal |
| 21 | Intentional Dose Omission | 20 | 4.8 | 4.9 | signal |
| 22 | Complication Of Device Removal | 12 | 4.7 | 4.7 | signal |
| 23 | Panic Attack | 25 | 4.5 | 4.6 | signal |
| 24 | Migraine | 62 | 4.3 | 4.4 | signal |
| 25 | Complication Of Device Insertion | 12 | 4.3 | 4.3 | signal |
| 26 | Product Packaging Quantity Issue | 7 | 4.2 | 4.2 | signal |
| 27 | Autoimmune Disorder | 6 | 4.1 | 4.1 | signal |
| 28 | Acne | 45 | 3.9 | 3.9 | signal |
| 29 | Initial Insomnia | 6 | 3.9 | 3.9 | signal |
| 30 | Inappropriate Schedule Of Product Administration | 104 | 3.9 | 4.0 | signal |
| 31 | Impaired Quality Of Life | 8 | 3.7 | 3.7 | signal |
| 32 | Impaired Gastric Emptying | 7 | 3.6 | 3.6 | signal |
| 33 | Infusion Site Pain | 7 | 3.6 | 3.6 | signal |
| 34 | Blood Thyroid Stimulating Hormone Increased | 5 | 3.6 | 3.6 | signal |
| 35 | Dermatitis Contact | 6 | 3.5 | 3.5 | signal |
| 36 | Cholecystectomy | 6 | 3.5 | 3.5 | signal |
| 37 | Depression | 120 | 3.5 | 3.6 | signal |
| 38 | Crying | 19 | 3.4 | 3.5 | signal |
| 39 | Product Taste Abnormal | 7 | 3.4 | 3.4 | signal |
| 40 | Knee Operation | 5 | 3.4 | 3.4 | signal |
| 41 | Anxiety | 142 | 3.3 | 3.4 | signal |
| 42 | Ear Discomfort | 5 | 3.2 | 3.2 | signal |
| 43 | Expired Product Administered | 16 | 3.2 | 3.2 | signal |
| 44 | Brain Fog | 7 | 3.2 | 3.2 | signal |
| 45 | Deep Vein Thrombosis | 31 | 3.1 | 3.2 | signal |
| 46 | Insurance Issue | 7 | 3.1 | 3.1 | signal |
| 47 | Pulmonary Embolism | 44 | 3.0 | 3.1 | signal |
| 48 | Surgery | 26 | 3.0 | 3.0 | signal |
| 49 | Hunger | 6 | 2.9 | 2.9 | signal |
| 50 | Drug Effect Less Than Expected | 6 | 2.8 | 2.8 | signal |
| 51 | Suicidal Ideation | 39 | 2.8 | 2.8 | signal |
| 52 | Injury | 30 | 2.8 | 2.8 | signal |
| 53 | Feeling Jittery | 8 | 2.8 | 2.8 | signal |
| 54 | Device Dislocation | 18 | 2.7 | 2.7 | signal |
| 55 | Affect Lability | 4 | 2.7 | 2.7 | no signal |
| 56 | Apathy | 6 | 2.7 | 2.7 | signal |
| 57 | Product Administration Error | 8 | 2.6 | 2.7 | signal |
| 58 | Abdominal Pain Lower | 10 | 2.6 | 2.6 | signal |
| 59 | Sluggishness | 4 | 2.6 | 2.6 | no signal |
| 60 | Poor Quality Product Administered | 4 | 2.6 | 2.6 | no signal |
| 61 | Euphoric Mood | 4 | 2.6 | 2.6 | no signal |
| 62 | Inappropriate Schedule Of Drug Administration | 28 | 2.6 | 2.6 | signal |
| 63 | Product Substitution Issue | 22 | 2.5 | 2.5 | signal |
| 64 | Product Prescribing Error | 9 | 2.5 | 2.5 | signal |
| 65 | Product Dose Omission Issue | 106 | 2.5 | 2.5 | signal |
| 66 | Unevaluable Event | 28 | 2.4 | 2.5 | signal |
| 67 | Irritability | 22 | 2.4 | 2.4 | signal |
| 68 | Product Storage Error | 31 | 2.4 | 2.4 | signal |
| 69 | Drug Dose Omission | 60 | 2.4 | 2.4 | signal |
| 70 | Paranoia | 6 | 2.3 | 2.3 | no signal |
| 71 | Impaired Work Ability | 7 | 2.2 | 2.2 | no signal |
| 72 | Procedural Pain | 9 | 2.1 | 2.2 | signal |
| 73 | Product Packaging Issue | 3 | 2.1 | 2.1 | no signal |
| 74 | Eczema | 16 | 2.1 | 2.1 | signal |
| 75 | Drug Prescribing Error | 6 | 2.0 | 2.0 | no signal |
| 76 | Device Breakage | 12 | 2.0 | 2.0 | signal |
| 77 | Product Physical Issue | 6 | 2.0 | 2.0 | no signal |
| 78 | Incorrect Product Storage | 4 | 2.0 | 2.0 | no signal |
| 79 | Product Dose Omission In Error | 8 | 2.0 | 2.0 | no signal |
| 80 | Intentional Self-injury | 6 | 2.0 | 2.0 | no signal |
| 81 | Incorrect Product Administration Duration | 6 | 2.0 | 2.0 | no signal |
| 82 | Unintended Pregnancy | 3 | 1.9 | 1.9 | no signal |
| 83 | Abortion Spontaneous | 11 | 1.8 | 1.8 | no signal |
| 84 | Circumstance Or Information Capable Of Leading To Medication Error | 9 | 1.8 | 1.8 | no signal |
| 85 | Anger | 9 | 1.7 | 1.8 | no signal |
| 86 | Mania | 4 | 1.6 | 1.6 | no signal |
| 87 | Dermatitis Atopic | 12 | 1.6 | 1.6 | no signal |
| 88 | Injection Site Irritation | 3 | 1.6 | 1.6 | no signal |
| 89 | Injection Site Rash | 7 | 1.5 | 1.5 | no signal |
| 90 | Ankylosing Spondylitis | 3 | 1.5 | 1.5 | no signal |
| 91 | Injection Site Swelling | 17 | 1.5 | 1.5 | no signal |
| 92 | Wrong Technique In Product Usage Process | 45 | 1.5 | 1.5 | no signal |
| 93 | Hair Texture Abnormal | 3 | 1.5 | 1.5 | no signal |
| 94 | Aggression | 11 | 1.4 | 1.4 | no signal |
| 95 | Injection Site Reaction | 15 | 1.4 | 1.4 | no signal |
| 96 | Device Issue | 19 | 1.4 | 1.4 | no signal |
| 97 | Emotional Distress | 26 | 1.4 | 1.4 | no signal |
| 98 | Withdrawal Syndrome | 9 | 1.4 | 1.4 | no signal |
| 99 | Injection Site Urticaria | 5 | 1.4 | 1.4 | no signal |
| 100 | Extra Dose Administered | 8 | 1.3 | 1.3 | no signal |
| 101 | Device Failure | 3 | 1.3 | 1.3 | no signal |
| 102 | Injection Site Bruising | 15 | 1.3 | 1.3 | no signal |
| 103 | Multiple Sclerosis Relapse | 13 | 1.2 | 1.2 | no signal |
| 104 | Premature Delivery | 3 | 1.2 | 1.2 | no signal |
| 105 | Application Site Pain | 4 | 1.2 | 1.2 | no signal |
| 106 | Product Quality Issue | 24 | 1.2 | 1.2 | no signal |
| 107 | Skin Irritation | 8 | 1.2 | 1.2 | no signal |
| 108 | Injection Site Pruritus | 11 | 1.1 | 1.1 | no signal |
| 109 | Product Complaint | 4 | 1.1 | 1.1 | no signal |
| 110 | Skin Burning Sensation | 11 | 1.0 | 1.0 | no signal |
| 111 | Device Expulsion | 9 | 0.9 | 0.9 | no signal |
| 112 | Injection Site Mass | 5 | 0.9 | 0.9 | no signal |
| 113 | Application Site Pruritus | 3 | 0.9 | 0.9 | no signal |
| 114 | Device Difficult To Use | 8 | 0.8 | 0.8 | no signal |
| 115 | Incorrect Dose Administered By Device | 3 | 0.8 | 0.8 | no signal |
| 116 | Application Site Erythema | 3 | 0.8 | 0.8 | no signal |
| 117 | Injection Site Haemorrhage | 9 | 0.7 | 0.7 | no signal |
| 118 | Accidental Exposure To Product | 10 | 0.7 | 0.7 | no signal |